Active • Host: E. coli • AA: 1,480-1,803 • MW: 35.7 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MERS-CoV Papain-like Protease (recombinant)

Item No. 40988

Technical Information
Synonyms
  • MERS-CoV PLpro
  • Middle East Respiratory Syndrome Coronavirus PLpro
Purity
≥80%
Source
Active recombinant MERS-CoV PLpro expressed in E. coli
Amino Acids
1,480-1,803
MW
35.7 kDa
50 mM Tris, pH 7.5, with 100 mM sodium chloride, 10% glycerol, and 1 mM DTT
Host
E. coli
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Middle East respiratory syndrome coronavirus (MERS-CoV) is an enveloped positive-stranded RNA virus, a member of the Betacoronavirus genus, and the causative agent of MERS, an acute respiratory disease that often leads to pneumonia and renal failure.1,2 The MERS-CoV papain-like protease (PLpro) is encoded by the non-structural protein 3 (nsp3) region of ORF1a.3,4 It cleaves non-structural proteins 1-3, which, together with non-structural proteins 4-16, form the replicase complex. In addition, it reverses certain post-translational modifications from host proteins, preferentially removing interferon-stimulated gene product 15 (ISG15) but also removing ubiquitin, with both actions leading to suppression of the host innate immune response.5 MERS-CoV PLpro decreases MDA5-induced mRNA expression of CXCL10, IFNB, and CCL5 and inhibits TNF-α-induced activation of NF-κB in vitro. Cayman’s MERS-CoV Papain-like Protease (recombinant) protein can be used for enzyme activity, surface plasmon resonance (SPR), and Western blot (WB) applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Du, L., Yang, Y., Zhou, Y., et alMERS-CoV spike protein: A key target for antivirals. Expert Opin. Ther. Targets 21(2), 131-143 (2017).

    2. Rabaan, A.A., Al-Ahmed, S.H., Haque, S., et alSARS-CoV-2, SARS-CoV, and MERS-CoV: A comparative overview. Infez. Med. 28(2), 174-184 (2020).

    3. Clasman, J.R., Báez-Santos, Y., Mettelman, R.C., et alX-ray structure and enzymatic activity profile of a core papain-like protease of MERS coronavirus with utility for structure-based drug design. Sci. Rep. 7, 40292 (2017).

    4. Li, Y.-H., Hu, C.-Y., Wu, N.-P., et alMolecular characteristics, functions, and related pathogenicity of MERS-CoV proteins. Engineering (Beijing) 5(5), 940-947 (2019).

    5. Mielech, A.M., Kilianski, A., Baez-Santos, Y.M., et alMERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology 450-451, 64-70 (2014).